
    
      Study participants will be followed up, under existing protocol derived from a study protocol
      developed by the "Union internationale contre les maladies respiratoires" and carried out
      already in 9 Africans countries. Participants will be hospitalised for at least four month,
      period which they will be given treatments, assessed for adverse events, monitored for TB-MR
      strains using culture techniques, at the monthly basis. If patients found with negative
      sputum culture at month four they will be dischrged from the hospital, and then treated four
      an additional five montns and then follow up, clinically and biologically for an additional
      six months before being declared as cured.
    
  